Clinical Trial Update: Ethnic Differences in Mechanisms of Action of Dupilumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial at University of Michigan is investigating ethnic differences in dupilumab's mechanisms of action for atopic dermatitis and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University of Michigan | Conditions: Atopic Dermatitis | Phase 4 | Status: RECRUITING